CANY
ARNA

Caxton Associates (New York)’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Caxton Associates (New York)’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,425
Closed -$256K – 365
2020
Q3 		$256K Sell
3,425
-1,218
-26% -$81.2K 0.03% 224
2020
Q2 		$292K Sell
4,643
-882
-16% -$48.5K 0.03% 267
2020
Q1 		$232K Buy
+5,525
New +$253K 0.04% 312

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Caxton Associates (New York)'s ARNA Position: Q4 2020 in Review

Caxton Associates (New York) sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 3,425 shares — an estimated $256K sold.

Caxton Associates (New York) first reported a position in ARNA in Q1 2020 and held it in 3 quarters. The position peaked at $292K in Q2 2020. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Caxton Associates (New York) reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,425 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $256K.
  • Caxton Associates (New York) first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 3 quarters.
  • Caxton Associates (New York)'s Arena Pharmaceuticals Inc position peaked at $292K in Q2 2020.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Caxton Associates (New York)'s 13F filing for Q4 2020, filed 16 Feb 2021.